Weekly Digest – July 2024 Weekly Digest – July 2024 26 July 2024: Nectin Therapeutics Licenses Novel ADC-Related Antibodies to Immunome Nectin Therapeutics announced a global, exclusive license agreement with Immunome Inc. for a panel of antibodies targeting an undisclosed […]
Weekly Digest – July 2024 Weekly Digest – July 2024 26 July 2024: BeiGene Opens U.S. Facility to Boost ADC Development and Global Oncology Reach BeiGene has opened its flagship U.S. facility in Hopewell, N.J., featuring state-of-the-art biologics manufacturing and […]
Weekly Digest – July 2024 Weekly Digest – July 2024 26 July 2024: Enhertu Faces Sales Challenges Amid Expansion Efforts by AstraZeneca and Daiichi Sankyo AstraZeneca counts on Daiichi Sankyo-partnered Enhertu as a significant growth driver, with expectations of over $5 […]
